SurgAR
PrivateLast Round
Series A
Sep 26, 2024
Total Funding Raised
$14.36M
Company Overview
SurgAR operates in Healthcare & Life Sciences and is based in Clermont-Ferrand. Its latest recorded funding round was a Series A round in September 2024.
SurgAR is a healthcare technology company that develops AI-powered augmented reality software to assist surgeons during minimally invasive laparoscopic procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, AR/VR Experiences, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SurgAR Comparables
Compare SurgAR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediView XR, Inc. | 85% | |
| Medivis | 82% | |
| Scopia Surgical | 79% |
For institutional investors. Book with your work email.
SurgAR Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 26, 2024 | ||||
| Seed | Oct 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SurgAR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elaia Partners | Series A |
| Banque Populaire Auvergne Rhône-Alpes | Series A |
| UI Investissement | Series A |
| Kreaxi | Seed |
| Clermont Auvergne Innovation | Series A, Seed |
| XAnge | Series A |
| Sofimac Investment Managers | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 160% MoM.
- Sep 18, 2025
Attended the ESGE Congress in Istanbul, Turkey.
For institutional investors. Book with your work email.
SurgAR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SurgAR's valuation, stock price, and market status.
Is SurgAR a public or private company?
SurgAR is a private company.
What is the current stock price of SurgAR?
SurgAR is a private company, so its shares have no public market price. Caplight tracks SurgAR's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SurgAR worth (valuation)?
Valuation information for SurgAR is not publicly available.
Can I buy SurgAR stock?
SurgAR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SurgAR's last funding round?
SurgAR's most recent funding round was Series A on September 26, 2024.
Who are the main investors in SurgAR?
Key investors in SurgAR include Elaia Partners, Banque Populaire Auvergne Rhône-Alpes, UI Investissement, Kreaxi, Clermont Auvergne Innovation.
Will SurgAR IPO soon?
No public IPO plans have been announced for SurgAR.
How can I track SurgAR secondary market activity?
Caplight tracks bids, offers, and trades in SurgAR's shares on secondary markets.